Azacyclonol: Difference between revisions
Appearance
Content deleted Content added
Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'CAS_number'). |
change generic short description |
||
(44 intermediate revisions by 33 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Medication which diminishes hallucinations}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
| verifiedrevid = 458783562 |
|||
| IUPAC_name = Diphenyl(piperidin-4-yl)methanol |
| IUPAC_name = Diphenyl(piperidin-4-yl)methanol |
||
| image = Azacyclonol. |
| image = Azacyclonol.svg |
||
<!--Clinical data--> |
<!--Clinical data--> |
||
| tradename = |
| tradename = |
||
| legal_AU = |
|||
| legal_BR = C1 |
|||
| legal_BR_comment = <ref>{{Cite web |author=Anvisa |author-link=Brazilian Health Regulatory Agency |date=2023-03-31 |title=RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial |trans-title=Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control|url=https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |url-status=live |archive-url=https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |archive-date=2023-08-03 |access-date=2023-08-16 |publisher=[[Diário Oficial da União]] |language=pt-BR |publication-date=2023-04-04}}</ref> |
|||
| legal_US = |
|||
| legal_UK = |
|||
| legal_UN = |
|||
| legal_status = Rx-only |
| legal_status = Rx-only |
||
| routes_of_administration = Oral |
| routes_of_administration = [[Oral administration|Oral]] |
||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite|changed|??}} |
|||
| CAS_number = |
| CAS_number = 115-46-8 |
||
| CAS_supplemental = <br />{{CAS|1798-50-1}} ([[Hydrochloride|HCl]]) |
| CAS_supplemental = <br />{{CAS|1798-50-1}} ([[Hydrochloride|HCl]]) |
||
| ATC_prefix = none |
| ATC_prefix = none |
||
| PubChem = 15723 |
| PubChem = 15723 |
||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|||
| ChemSpiderID = 14952 |
| ChemSpiderID = 14952 |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
| UNII_Ref = {{fdacite|correct|FDA}} |
||
| UNII = 2MMR990PEM |
| UNII = 2MMR990PEM |
||
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
|||
| ChEMBL = 127508 |
| ChEMBL = 127508 |
||
| synonyms = MER-17 |
| synonyms = MER-17; MDL-4829; Diphenylmethanolpiperidine |
||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=18 | H=21 | N=1 | O=1 |
| C=18 | H=21 | N=1 | O=1 |
||
⚫ | |||
| molecular_weight = 267.37 g/mol |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|||
⚫ | |||
| StdInChI = 1S/C18H21NO/c20-18(15-7-3-1-4-8-15,16-9-5-2-6-10-16)17-11-13-19-14-12-17/h1-10,17,19-20H,11-14H2 |
| StdInChI = 1S/C18H21NO/c20-18(15-7-3-1-4-8-15,16-9-5-2-6-10-16)17-11-13-19-14-12-17/h1-10,17,19-20H,11-14H2 |
||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|||
| StdInChIKey = ZMISODWVFHHWNR-UHFFFAOYSA-N |
| StdInChIKey = ZMISODWVFHHWNR-UHFFFAOYSA-N |
||
}} |
}} |
||
'''Azacyclonol''' (trade names '''Ataractan''', '''Calmeran''', '''Frenoton''', '''Frenquel''', '''Psychosan'''), also known as '''γ- |
'''Azacyclonol''' (trade names '''Ataractan''', '''Calmeran''', '''Frenoton''', '''Frenquel''', '''Psychosan'''), also known as '''γ-[[pipradrol]]''', is a [[drug]] which is an [[ataractive]]; an agent which diminishes [[hallucination]]s in [[psychotic]] individuals.<ref name="pmid13368052">{{Cite journal | vauthors = BRAUN DL, BROWN BB, FELDMAN RG | title = The pharmacologic activity of alpha-(4-piperidyl)-benzhydrol hydrochloride (azacyclonol hydrochloride); an ataractive agent | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 118 | issue = 2 | pages = 153–61 | date = October 1956 | pmid = 13368052 | url = http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=13368052 | access-date = 2010-04-16 | archive-date = 2019-12-08 | archive-url = https://web.archive.org/web/20191208002146/http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=13368052 | url-status = dead }}</ref><ref name="isbn3-88763-075-0">{{Cite book| author = Swiss Pharmaceutical Society | title = Index Nominum 2000: International Drug Directory (Book with CD-ROM) | publisher = Medpharm Scientific Publishers | location = Boca Raton | year = 2000 | isbn = 3-88763-075-0 | url = https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA84}}</ref> It has also been called a [[tranquilizer]] and [[antipsychotic]], though these definitions are not accurate as it does not actually possess such properties. Despite being a [[positional isomer]] of [[pipradrol]], it is not a [[psychostimulant]], and instead has mild [[depressant]] effects.<ref name="pmid13368052"/><ref name="pmid13944436">{{Cite journal| author = FARRANT J | title = Interactions between cocaine, tyramine and noradrenaline at the noradrenaline store | journal = [[British Journal of Pharmacology and Chemotherapy]] | volume = 20 | issue = 3| pages = 540–9 |date=June 1963 | pmid = 13944436 | pmc = 1703814 | doi = 10.1111/j.1476-5381.1963.tb01491.x}}</ref> |
||
The drug was introduced in [[Europe]] in the mid |
The drug was introduced in [[Europe]] in the mid-1950s for the treatment of [[schizophrenia]] likely because it was found to attenuate the subjective [[psychedelic drug|psychedelic]] effects of [[lysergic acid diethylamide|LSD]] and [[mescaline]] in humans.<ref name="pmid13368052"/><ref name="pmid13383414">{{Cite journal|vauthors=FORSTER W, HENDERSON AL | title = A clinical study of Frenquel (alpha (4-piperidyl) benzhydrol hydrochloride) in chronic schizophrenia | journal = Canadian Medical Association Journal | volume = 76 | issue = 2 | pages = 97–101 |date=January 1957 | pmid = 13383414 | pmc = 1823487 }}</ref> However, due to poor and mixed clinical effectiveness,<ref name="pmid13383414"/> it never gained widespread acceptance and was eventually discontinued. |
||
Azacyclonol is also known as '''diphenylmethanolpiperidine''' and is the [[parent structure]] of the [[antihistamine]]s [[fexofenadine]] and [[terfenadine]]. Terfenadine produces azacyclonol as a major [[active metabolite]].<ref name="pmid8738042">{{Cite journal| author = Martens J | title = Determination of the terfenadine metabolite azacyclonol in human serum using gas chromatography-mass spectrometry | journal = Journal of Chromatography B | volume = 678 | issue = 2 | pages = 349–53 |date=April 1996 | pmid = 8738042 | doi = 10.1016/0378-4347(95)00561-7}}</ref> |
|||
It is made by the organometallic addition of 4-bromopyridine to [[benzophenone]], followed by catalytic hydrogenation of the pyridine heteroaromatic ring system to the corresponding piperidine.<ref>Campen Jr Marcus G Van, Pogge Raymond C, Schumann Edward L; [[Marion Merrell Dow|Wm S Merrell Co]]; {{US patent|2804422}} (1957).</ref> |
|||
==See also== |
|||
* [[Pipradrol]] |
|||
* [[Terfenadine]] |
|||
* [[Fexofenadine]] |
|||
==References== |
==References== |
||
Line 44: | Line 54: | ||
[[Category:Antipsychotics]] |
[[Category:Antipsychotics]] |
||
[[Category: |
[[Category:Drugs with unknown mechanisms of action]] |
||
[[Category: |
[[Category:4-Piperidinyl compounds]] |
||
[[Category:Tertiary alcohols]] |